Graham Capital Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $499K | Sell |
28,045
-23,746
| -46% | -$423K | 0.01% | 782 |
|
|
2025
Q1 | $923K | Buy |
51,791
+30,082
| +139% | +$536K | 0.02% | 552 |
|
|
2024
Q4 | $647K | Sell |
21,709
-31,236
| -59% | -$931K | 0.01% | 628 |
|
|
2024
Q3 | $828K | Buy |
+52,945
| New | +$828K | 0.01% | 475 |
|
|
2024
Q2 | – | Sell |
-18,716
| Closed | -$293K | – | 1244 |
|
|
2024
Q1 | $293K | Sell |
18,716
-45,190
| -71% | -$706K | 0.01% | 772 |
|
|
2023
Q4 | $954K | Buy |
+63,906
| New | +$954K | 0.02% | 378 |
|
|
2023
Q3 | – | Sell |
-17,726
| Closed | -$736K | – | 1197 |
|
|
2023
Q2 | $736K | Buy |
17,726
+13,540
| +323% | +$562K | 0.02% | 435 |
|
|
2023
Q1 | $252K | Buy |
+4,186
| New | +$252K | 0.01% | 902 |
|
|
2022
Q3 | – | Sell |
-12,339
| Closed | -$857K | – | 1224 |
|
|
2022
Q2 | $857K | Buy |
+12,339
| New | +$857K | 0.03% | 482 |
|